The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often at Series D+ and in Healthtech.
Morgan Health is a division of JPMorganChase focused on improving the quality, affordability and equity of health care in the United States.
Corporate venture armmorganhealth.comRounds from 2025-09-25 to 2026-09-02
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Thyme Care Thyme Care enhances the cancer journey with expert oncology navigation and an oncology care team, partnering to improve access, outcomes, and costs. | Series E Verified against 4 of 8 sources | $125M | 2026-09-02 | [ LEAD ] |
Series D+ Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $366M |
| 2026-01-30 |
| [ PART ] |
Thyme Care Thyme Care enhances the cancer journey with expert oncology navigation and an oncology care team, partnering to improve access, outcomes, and costs. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $97M | 2025-09-25 | [ PART ] |